|
National Stock Number(NSN): 6505-00-368-5927 (6505003685927, 003685927)
| NIIN: |
00-368-5927 |
Item Name: |
GUAIFENESIN SYRUP |
INC: |
34123
|
| FSC: |
6505
|
Assignment Date: |
Mar-03-1974 |
CRIT: |
X |
IIG: |
34123 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9276 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
0 |
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
054-8318-04 |
34471
|
BOEHRINGER INGELHEIM ROXANE, INC. |
H |
3 |
9 |
4 |
75 |
3 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER |
| CQCT |
PRIMARY CONTAINER TYPE |
CUP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
15.000 MILLILITERS |
| CRXL |
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER |
10 CUP |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
100 |
| CSCX |
TOTAL SECONDARY CONTAINER QUANTITY |
10 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
GUAIFENESIN ORAL SOLUTION |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|